US 9011857
Methods of treating cancer by administering EMP2 antibodies
granted A61KA61K39/39558A61K45/06
Quick answer
US patent 9011857 (Methods of treating cancer by administering EMP2 antibodies) held by The Regents of the University of California expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K39/39558, A61K45/06, A61P, A61P35/00